CTRI/2026/07/113631进行中（未招募）不适用
Therapeutic Drug Monitoring of Azathioprine 6 TGN and 6 MMP in inflammatory Bowel Disease A Pilot Study - NIL
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adults aged 18 years or older with a confirmed diagnosis of Crohns disease or
- •ulcerative colitis.
- •Currently receiving azathioprine therapy for maintenance of remission on Azathioprine
- •stable dose, for a minimum of 8 weeks prior to enrollment.
- •Able and willing to provide written informed consent.
排除标准
- •Concurrent therapy with allopurinol or febuxostat, as these alter thiopurine metabolism.
- •Presence of an acute severe IBD flare requiring hospitalization at the time of screening.
- •Pregnant or lactating women, due to potential drug related risks.
- •Refusal to participate or inability to provide consent.
研究组 & 干预措施
Intervention1: Azathioprine therapy as part of routine clinical care: This is an observational cohort study. Patients with inflammatory bowel disease receiving azathioprine as part of routine clinical management will undergo therapeutic drug monitoring of 6 TGN and 6 MMP metabolite levels. No study specific intervention, treatment allocation, randomization, or modification of treatment will be performed by the investigators.
干预措施: Intervention1: Azathioprine therapy as part of routine clinical care: This is an observational cohort study. Patients with inflammatory bowel disease receiving azathioprine as part of routine clinical management will undergo therapeutic drug monitoring of 6 TGN and 6 MMP metabolite levels. No study specific intervention, treatment allocation, randomization, or modification of treatment will be performed by the investigators.
研究者
相似试验
尚未招募
不适用
A study to understand the use and scope of drug levels monitoring in patients given voriconazole for invasive fungal diseases.Aspergillosis, (2) ICD-10 Condition: B37||Candidiasis, (3) ICD-10 Condition: B470||Eumycetoma, (4) ICD-10 Condition: B38||Coccidioidomycosis, (5) ICD-10 Condition: B45||Cryptococcosis, (6) ICD-10 Condition: B479||Mycetoma, unspecified,CTRI/2025/09/094962IPGMER and SSKM Hospital15
尚未招募
不适用
Optimization of Therapeutic Drug Monitoring in Pediatric Kidney TransplantKidney TransplantNCT07769567Children's Hospital Medical Center, Cincinnati25
招募中
不适用
Safety verification of therapeutic drug monitoring for BusulfanCentral nervous system lymphomajRCT103126018410
尚未招募
不适用
Analysis of Mycophenolic Acid in saliva matrix in Renal Transplant patientsEnd stage renal disease,CTRI/2024/12/077757Department of Pharmacology30
尚未招募
不适用
A study on monitoring the Drug Levels of Antibiotics Like Amikacin and Vancomycin: A Clinical StudySepsis due to other Gram-negativeorganisms,CTRI/2025/10/09669430